News
Natalie Schnaitmann discusses the importance of self-advocacy and access to second opinions when symptoms are dismissed among ...
Five years after my transplant for leukemia, I’m learning to focus on gratitude despite daily struggles, remembering that ...
The first patient has been dosed in the phase 3 TERZO trial of Copiktra for relapsed or refractory nodal T-follicular helper ...
It is important to understand why it is vital that patients and survivors of cancer take steps to reduce the body’s burden ...
Let’s get straight to the point: a good nurse can change your experience with cancer and cancer treatment.
Michelle Kirschner discusses the how patients can foster a strong network of supporters from diagnosis through survivorship.
Dr. Jared Weiss walks patients through the therapeutic potential viability of intratumoral therapies among those with lung ...
Using a 14-gene test to guide chemotherapy significantly improved disease-free survival in patients with early nonsquamous ...
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
The dual-targeting CAR T-cell therapy KITE-363 showed positive response rates and manageable side effects in relapsed or ...
The FDA granted orphan drug designation to MVdeltaC, a measles virus-based immunotherapy, for pleural mesothelioma, ...
Adding Zyprexa to ondansetron cut nausea and vomiting safely in abdominal/pelvic radiation with low-emetogenic capecitabine.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results